cdk4 glutathione Discovery of the GSH responsive “Y-PROTACs” targeting ALK and CDK4/6 as a potential treatment for cancer Cyclin D-Cdk4,6 drives cell cycle
Cyclin D Cdk4,6 drives cell cycle progression via the retinoblastoma protein's C terminal helix bioRxiv Breaking Cancer's Momentum: CDK4 6 Inhibitors and the Promise of Combination Therapy Diet metabolism transcription axis modulates the sensitivity to CDK4 6 inhibitors through RB1 in prostate cancer: Cell Reports reduced glutathione and breast cancer SLC7A11 protects luminal A breast cancer cells against ferroptosis induced by Cyclin D CDK4 Disulfide Bond Attenuates Pulmonary Vascular Cell Proliferation Circulation Research Targeting CDK4 6 for Anticancer Therapy
Pay in 4 interest-free payments of $7.26 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 4 - Aug 9





